Virdee, A. K., Knudtzen, F. C., Llibre, J. M., Omland, L. H., Obel, N.
, Stærke, N. B., Åhsberg, J., Ørsted, I., Kronborg, G.
, Mohey, R., Montejo, M. D. P. F., Johansen, I. S. & Martin-Iguacel, R. (2025).
Risk of Tuberculosis After Achieving HIV Virological Suppression on Antiretroviral Therapy: A Danish Nationwide Prospective Cohort Study.
Clinical Infectious Diseases,
80(4), 854-863.
https://doi.org/10.1093/cid/ciae499Højte, C., Olsen, M. F., Faurholt-Jepsen, D., Jørgensen, M. H., Pressler, T., Leo-Hansen, C., Bryrup, T.
, Jeppesen, M., Olesen, H. V., Petersen, J., Katzenstein, T. L., Nielsen, B. U., Skov, M. & the TransformCF study group (2025).
Severe hepatotoxicity is uncommon following the introduction of Elexacaftor/Tezacaftor/Ivacaftor: A real-world two-years follow-up study of the Danish cystic fibrosis cohort.
Journal of Cystic Fibrosis,
24(5), 998-1005.
https://doi.org/10.1016/j.jcf.2025.08.008Skouvig Pedersen, O., Butova, T., Miasoiedov, V., Feshchenko, Y., Kuzhko, M., Niemann, S., Rosenthal, A., Grinev, A., Rosenfeld, G., Hoppes, M. D., Kilmnick, J., Crudu, V., Ciobanu, N., Codreanu, A., Toxanbayeva, B., Chingissova, L., Yurko, K., Kucheriavchenko, V., Vekshyn, V. ... Butov, D. (2025).
Sex differences in risk factors for unsuccessful tuberculosis treatment outcomes in Eastern Europe from 2020 to 2022: a multi-country retrospective cohort study.
The Lancet Regional Health - Europe,
55, Artikel 101354.
https://doi.org/10.1016/j.lanepe.2025.101354Cham, L. B., Hamdan, T. A., Bhat, H., Tabbara, K. S., Farid, E., Barbouche, M. R. & Adomati, T. (2025).
SIRPα is An Inhibitory Receptor That Regulates NK Cell Activation and Function.
Cellular Physiology and Biochemistry,
59(5), 652-665.
https://doi.org/10.33594/000000816
Salmanton-García, J., Guerra Maio, A., Stahl, J. P., de Barra, E.
, Jensen-Fangel, S., Torti, C., Kraef, C., Miró, J. M., Verbon, A., Cornely, O. A., Beeching, N. J. & European Union of Medical Specialists Infectious Diseases Section and the Trainee Association of the European Society of Clinical Microbiology and Infectious Diseases (2025).
Specialist training in infectious diseases in Europe.
Clinical Microbiology and Infection,
31(6), 1003-1010.
https://doi.org/10.1016/j.cmi.2024.12.026Zhang, B.-C., Pedersen, A., Reinert, L. S., Li, Y.
, Narita, R., Idorn, M., Hu, L., Skouboe, M. K., Li, S.
, Maimaitili, M., Ding, X., Cong, Y., Zhao, J., Frémond, M.-L.
, Mikkelsen, K., Gao, Z., Huang, J.-R.
, Thomsen, E. A., Mikkelsen, J. H. ... Paludan, S. R. (2025).
STING signals to NF-κB from late endolysosomal compartments using IRF3 as an adaptor.
Nature Immunology,
26(11), 1916-1930.
https://doi.org/10.1038/s41590-025-02283-8
Agergaard, J., Frostholm, L., Fink, P. K., Dantoft, T. M.
, Schiøttz-Christensen, B. & Petersen, M. W. (2025).
Symptom profiles in long COVID compared to functional somatic disorder and the general population.
Danish Medical Journal,
72(10), Artikel A09240627.
https://doi.org/10.61409/A09240627
Wolff, J. H., Skov, T. W., Haslund, D., Dorset, S. R., Revenfeld, A. L. S., Aussel, C.
, Jørgensen, S. E., Holm, M., Thomsen, M. K., Ammann, S., Cathomen, T.
, Mogensen, T. H., Møller, B. K., Bak, R. O. & Mikkelsen, J. G. (2025).
Targeted gene editing and near-universal cDNA insertion of CYBA and CYBB as a treatment for chronic granulomatous disease.
Nature Communications,
16(1), Artikel 7475.
https://doi.org/10.1038/s41467-025-62738-2